CRIPS and Prof John Beltrame AM/CEO Innovation Award

The following information needs to be provided.

• Investigator information
• Project details (250 words) 

1. Title
2. Primary study question
3. Primary study implementation outcome measured
4. Lay description
5. Benefit to CALHN patients
6. Digital or data recording component (yes/no)

A shortlist of applications will be selected by an external panel and invited to submit a full application.

Applications for CALHN CEO CRIPS Grants will be a two-step process.

1. Expression of interest

This initial application step will include the clinical research team details and a project synopsis, which will be evaluated by an external assessment panel.

 Submit an expression of interest form.

2. Invited full application

Top ranked expressions of interest will be invited to submit a full application.

Full applications will be evaluated by the CALHN executive expert panel (i.e. CALHN governing and executive board, or other personnel at the discretion of the CALHN CEO) and may be requested to attend an interview.

Up to four (4) grants will be awarded.

Scores/rankings will not be disclosed to applicants. The review panel’s decision is final, and no further correspondence will be considered.

Timeline

These criteria include:

• Chief Investigator-A (CI-A, Principal Investigator) must be a member of the CALHN clinical staff working at CALHN sites:
   
  • Royal Adelaide Hospital
  • The Queen Elizabeth Hospital
  • Hampstead Rehabilitation Hospital
  • Mental health services at Glenside Health Service.
  • Statewide Rehabilitation Services at the Repat Health Precinct
     
• Up to 3 additional chief investigators (CI-B, C or D) may be included in the application but a staff member may only be listed as CI-A on one application.
  Note: We encourage diversity and inclusivity regarding Chief Investigators.
• Current CRIPS grant recipient chief investigators cannot be the CI-A for this application round but may fulfil the role of CI-B, C or D on other applications.
• The project must be primarily based within CALHN but collaboration with other institutions/networks is strongly encouraged.
• If funding is being sought to support the employment of the CIA, this must be at CALHN and not an external Institution.

After expressions of interest are screened for eligibility, the following scoring matrix will be used by external assessors to score each application.

Assessors will not assess an application if there is a direct conflict of interest.

The descriptions below are relevant to the table underneath.

*Why is the study important? (Study relevance)
**How it will be achieved? (Feasibility)
***The 'so what' expected outcomes/impact (Impact on patient care)

• Each grant award is a maximum of $200,000 (GST inclusive) over two years (i.e. $100,000 per financial year).
• Successful awards announced during CALHN Research Week in the same year of application.
• Note: ethics/governance requirements must be approved by July 2025.

• Funds will only be available from 1 July 2025 (up to $15,000 may be pre-released prior to July, to support staff preparing ethics/governance submissions).

  The following will be managed by CALHN research services:

  • collaboration and/or service agreements
  • financial statements – due 31 July 2026 and 2027
  • reporting - all reports should be submitted to CALHN research grants team on the reporting template provided to grant recipients
     
    • progress reports - due 6 monthly
       
      • 31 Jan 2026
      • 31 Jul 2026
      • 31 Jan 2027
         
  • final report - due 30 September 2026
     
• progress reports to document continued compliance with eligibility criteria
• CIs to notify CALHN Communication and Engagement team regarding promotional opportunities by visiting the CALHN intranet website
• Acknowledgement of funding support from the RAH Research Fund must be included in any presentation/paper arising from the research. Use the following acknowledgement:
  • funding for the study was provided by a competitive research grant from the Clinical Rapid Implementation Project Scheme of CALHN, funded by the RAH Research Fund administered by the Health Services Charitable Gifts Board (HSCGB)
• Project grant may be terminated if above criteria are not fulfilled.